130 related articles for article (PubMed ID: 12899243)
1. SAR: flavonoids and COX-2 inhibition.
Rosenkranz HS; Thampatty BP
Oncol Res; 2003; 13(12):529-35. PubMed ID: 12899243
[TBL] [Abstract][Full Text] [Related]
2. Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship.
Mutoh M; Takahashi M; Fukuda K; Komatsu H; Enya T; Matsushima-Hibiya Y; Mutoh H; Sugimura T; Wakabayashi K
Jpn J Cancer Res; 2000 Jul; 91(7):686-91. PubMed ID: 10920275
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors.
Rao PN; Uddin MJ; Knaus EE
J Med Chem; 2004 Jul; 47(16):3972-90. PubMed ID: 15267236
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models.
Palomer A; Cabré F; Pascual J; Campos J; Trujillo MA; Entrena A; Gallo MA; García L; Mauleón D; Espinosa A
J Med Chem; 2002 Mar; 45(7):1402-11. PubMed ID: 11906281
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type.
Ulbrich H; Fiebich B; Dannhardt G
Eur J Med Chem; 2002 Dec; 37(12):953-9. PubMed ID: 12660020
[TBL] [Abstract][Full Text] [Related]
7. Atropisomeric myristinins: selective COX-2 inhibitors and antifungal agents from Myristica cinnamomea.
Sawadjoon S; Kittakoop P; Kirtikara K; Vichai V; Tanticharoen M; Thebtaranonth Y
J Org Chem; 2002 Aug; 67(16):5470-5. PubMed ID: 12153244
[TBL] [Abstract][Full Text] [Related]
8. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
Kalgutkar AS; Kozak KR; Crews BC; Hochgesang GP; Marnett LJ
J Med Chem; 1998 Nov; 41(24):4800-18. PubMed ID: 9822550
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids and stilbenoids with COX-1 and COX-2 inhibitory activity from Dracaena loureiri.
Likhitwitayawuid K; Sawasdee K; Kirtikara K
Planta Med; 2002 Sep; 68(9):841-3. PubMed ID: 12357401
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR
J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase active bioflavonoids from Balaton tart cherry and their structure activity relationships.
Wang H; Nair MG; Strasburg GM; Booren AM; Gray I; Dewitt DL
Phytomedicine; 2000 Mar; 7(1):15-9. PubMed ID: 10782485
[TBL] [Abstract][Full Text] [Related]
12. New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate cancer chemotherapy.
Pommery N; Taverne T; Telliez A; Goossens L; Charlier C; Pommery J; Goossens JF; Houssin R; Durant F; Hénichart JP
J Med Chem; 2004 Dec; 47(25):6195-206. PubMed ID: 15566290
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives.
Cho H; Yun CW; Park WK; Kong JY; Kim KS; Park Y; Lee S; Kim BK
Pharmacol Res; 2004 Jan; 49(1):37-43. PubMed ID: 14597150
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activities of 8-arylflavones.
Dao TT; Kim SB; Sin KS; Kim S; Kim HP; Park H
Arch Pharm Res; 2004 Mar; 27(3):278-82. PubMed ID: 15089030
[TBL] [Abstract][Full Text] [Related]
15. Efficient synthesis of [6-chloro-2-(4-chlorobenzoyl)-1H-indol-3-yl]-acetic acid, a novel COX-2 inhibitor.
Caron S; Vazquez E; Stevens RW; Nakao K; Koike H; Murata Y
J Org Chem; 2003 May; 68(10):4104-7. PubMed ID: 12737602
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors.
Khanapure SP; Garvey DS; Young DV; Ezawa M; Earl RA; Gaston RD; Fang X; Murty M; Martino A; Shumway M; Trocha M; Marek P; Tam SW; Janero DR; Letts LG
J Med Chem; 2003 Dec; 46(25):5484-504. PubMed ID: 14640557
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.
Song X; Lin HP; Johnson AJ; Tseng PH; Yang YT; Kulp SK; Chen CS
J Natl Cancer Inst; 2002 Apr; 94(8):585-91. PubMed ID: 11959891
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR of a new series of COX-2-selective inhibitors: pyrazolo[1,5-a]pyrimidines.
Almansa C; de Arriba AF; Cavalcanti FL; Gómez LA; Miralles A; Merlos M; García-Rafanell J; Forn J
J Med Chem; 2001 Feb; 44(3):350-61. PubMed ID: 11462976
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
Moreau A; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives.
Dao TT; Chi YS; Kim J; Kim HP; Kim S; Park H
Bioorg Med Chem Lett; 2004 Mar; 14(5):1165-7. PubMed ID: 14980657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
